| Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... The Lancet infectious diseases 14 (6), 498-509, 2014 | 962 | 2014 |
| Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020 | 729 | 2020 |
| Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R MN Neely, MG Van Guilder, WM Yamada, A Schumitzky, RW Jelliffe Therapeutic drug monitoring 34 (4), 467-476, 2012 | 506 | 2012 |
| More codeine fatalities after tonsillectomy in North American children LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ... Pediatrics 129 (5), e1343-e1347, 2012 | 441 | 2012 |
| Are vancomycin trough concentrations adequate for optimal dosing? MN Neely, G Youn, B Jones, RW Jelliffe, GL Drusano, KA Rodvold, ... Antimicrobial agents and chemotherapy 58 (1), 309-316, 2014 | 426 | 2014 |
| Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing MN Neely, L Kato, G Youn, L Kraler, D Bayard, M van Guilder, ... Antimicrobial agents and chemotherapy 62 (2), 10.1128/aac. 02042-17, 2018 | 369 | 2018 |
| Innovative approaches to optimizing the delivery of vancomycin in individual patients MP Pai, M Neely, KA Rodvold, TP Lodise Advanced drug delivery reviews 77, 50-57, 2014 | 312 | 2014 |
| Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents TJ Walsh, PC Adamson, NL Seibel, PM Flynn, MN Neely, C Schwartz, ... Antimicrobial agents and chemotherapy 49 (11), 4536-4545, 2005 | 295 | 2005 |
| Voriconazole pharmacokinetics and pharmacodynamics in children M Neely, T Rushing, A Kovacs, R Jelliffe, J Hoffman Clinical infectious diseases 50 (1), 27-36, 2010 | 259 | 2010 |
| Why has model‐informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future AS Darwich, K Ogungbenro, AA Vinks, JR Powell, JL Reny, N Marsousi, ... Clinical Pharmacology & Therapeutics 101 (5), 646-656, 2017 | 236 | 2017 |
| Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients DF Florescu, SA Pergam, MN Neely, F Qiu, C Johnston, SS Way, J Sande, ... Biology of Blood and Marrow Transplantation 18 (5), 731-738, 2012 | 195 | 2012 |
| International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious … JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... Lancet Infect Dis 14 (6), 498-509, 2014 | 178 | 2014 |
| Parental perspectives on immunizations: impact of the COVID-19 pandemic on childhood vaccine hesitancy K He, WJ Mack, M Neely, L Lewis, V Anand Journal of community health, 1-14, 2022 | 149 | 2022 |
| Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients LS Eiland, TM English, EH Eiland III Annals of Pharmacotherapy 45 (5), 582-589, 2011 | 132 | 2011 |
| Improved tacrolimus target concentration achievement using computerized dosing in renal transplant recipients—a prospective, randomized study E Størset, A Åsberg, M Skauby, M Neely, S Bergan, S Bremer, K Midtvedt Transplantation 99 (10), 2158-2166, 2015 | 130 | 2015 |
| First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected … PENPACT-1 (PENTA 9/PACTG 390) Study Team The Lancet infectious diseases 11 (4), 273-283, 2011 | 129 | 2011 |
| Adipocytes sequester and metabolize the chemotherapeutic daunorubicin X Sheng, JH Parmentier, J Tucci, H Pei, O Cortez-Toledo, ... Molecular cancer research 15 (12), 1704-1713, 2017 | 127 | 2017 |
| Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian T Tatarinova, M Neely, J Bartroff, M van Guilder, W Yamada, D Bayard, ... Journal of pharmacokinetics and pharmacodynamics 40, 189-199, 2013 | 122 | 2013 |
| Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy MN Neely, L Benning, J Xu, HD Strickler, RM Greenblatt, H Minkoff, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 44 (1), 38-42, 2007 | 121 | 2007 |
| Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy TW Felton, JA Roberts, TP Lodise, M Van Guilder, E Boselli, MN Neely, ... Antimicrobial agents and chemotherapy 58 (7), 4094-4102, 2014 | 103 | 2014 |
William HopeUniversity of LiverpoolVerified email at liverpool.ac.uk
